Diffusion Histology Imaging Combining Diffusion Basis Spectrum Imaging (DBSI) and Machine Learning Improves Detection and Classification of Glioblastoma Pathology

Zezhong Ye,Richard L. Price,Xiran Liu,Joshua Lin,Qingsong Yang,Peng Sun,Anthony T. Wu,Liang Wang,Rowland H. Han,Chunyu Song,Ruimeng Yang,Sam E. Gary,Diane D. Mao,Michael Wallendorf,Jian L. Campian,Jr-Shin Li,Sonika Dahiya,Albert H. Kim,Sheng-Kwei Song

DOI: https://doi.org/10.1158/1078-0432.ccr-20-0736

IF: 13.801

2020-07-21

Clinical Cancer Research

Abstract:PURPOSE: Glioblastoma (GBM) is one of the deadliest cancers with no cure. While conventional MRI has been widely adopted to examine GBM clinically, accurate neuroimaging assessment of tumor histopathology for improved diagnosis, surgical planning, and treatment evaluation remains an unmet need in the clinical management of GBMs.EXPERIMENTAL DESIGN: We employ a novel diffusion histology imaging (DHI) approach, combining diffusion basis spectrum imaging (DBSI) and machine learning, to detect, differentiate, and quantify areas of high cellularity, tumor necrosis, and tumor infiltration in GBM.RESULTS: Gadolinium-enhanced T1-weighted or hyperintense fluid-attenuated inversion recovery failed to reflect the morphologic complexity underlying tumor in patients with GBM. Contrary to the conventional wisdom that apparent diffusion coefficient (ADC) negatively correlates with increased tumor cellularity, we demonstrate disagreement between ADC and histologically confirmed tumor cellularity in GBM specimens, whereas DBSI-derived restricted isotropic diffusion fraction positively correlated with tumor cellularity in the same specimens. By incorporating DBSI metrics as classifiers for a supervised machine learning algorithm, we accurately predicted high tumor cellularity, tumor necrosis, and tumor infiltration with 87.5%, 89.0%, and 93.4% accuracy, respectively.CONCLUSIONS: Our results suggest that DHI could serve as a favorable alternative to current neuroimaging techniques in guiding biopsy or surgery as well as monitoring therapeutic response in the treatment of GBM.

oncology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is how to improve the accuracy of detection and classification of glioblastoma (GBM) pathological features by combining Diffusion Basis Spectrum Imaging (DBSI) and machine - learning techniques. Specifically, the research aims to: 1. **Detect and distinguish high - cell - density areas, tumor necrosis, and tumor infiltration**: Although MRI techniques commonly used in current clinical practice (such as gadolinium - enhanced T1 - weighted imaging and FLAIR imaging) are widely used in the diagnosis of GBM, these techniques cannot accurately reflect the microscopic structural complexity of the tumor, especially having limitations in distinguishing high - cell - density, necrotic, and infiltrated areas. Therefore, the researchers hope that through the combination of DBSI and machine learning, these pathological features can be detected and distinguished more accurately. 2. **Improve the accuracy of diagnosis, surgical planning, and treatment evaluation**: GBM is a highly lethal cancer, and there is currently no radical cure. Accurate neuroimaging evaluation is crucial for improving diagnosis, surgical planning, and treatment - effect evaluation. Existing MRI techniques have deficiencies in these aspects, and the researchers hope to make up for these deficiencies through a new imaging technique (i.e., Diffusion Histology Imaging, DHI), thereby providing more reliable decision - making basis for clinicians. 3. **Develop a non - invasive alternative method**: Currently, although the gold - standard surgical biopsy can provide accurate pathological information, it has certain risks. The researchers hope to develop a non - invasive imaging technique that can accurately reflect the pathological features of the tumor without surgery, thereby reducing the pain and risk of patients. In summary, the main objective of this paper is to develop a new imaging method (DHI) by combining DBSI and machine - learning techniques to improve the accuracy of detection and classification of GBM pathological features, and further improve the effects of clinical diagnosis, surgical planning, and treatment evaluation.

Diffusion Histology Imaging Combining Diffusion Basis Spectrum Imaging (DBSI) and Machine Learning Improves Detection and Classification of Glioblastoma Pathology

Diffusion tensor imaging‐based machine learning for <scp>IDH</scp> wild‐type glioblastoma stratification to reveal the biological underpinning of radiomic features

Histological and Molecular Classifications of Pediatric Glioma with Time-Dependent Diffusion MRI-based Microstructural Mapping.

Image-based deep learning identifies glioblastoma risk groups with genomic and transcriptomic heterogeneity: a multi-center study

Utilizing Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) to Analyze Interstitial Fluid Flow and Transport in Glioblastoma and the Surrounding Parenchyma in Human Patients

Machine-learning based classification of glioblastoma using delta-radiomic features derived from dynamic susceptibility contrast enhanced magnetic resonance images: Introduction.

Advanced diffusion imaging reveals microstructural characteristics of primary CNS lymphoma, allowing differentiation from glioblastoma

Automated Machine-Learning Framework Integrating Histopathological and Radiological Information for Predicting IDH1 Mutation Status in Glioma

AI Deployment on GBM Diagnosis: A Novel Approach to Analyze Histopathological Images Using Image Feature-Based Analysis

Hyperpolarized Magnetic Resonance Imaging, Nuclear Magnetic Resonance Metabolomics, and Artificial Intelligence to Interrogate the Metabolic Evolution of Glioblastoma

Clinical Assessment of Magnetic Resonance Spectroscopy and Diffusion-Weighted Imaging in Diffuse Glioma: Insights Into Histological Grading and IDH Classification

Exploring molecular glioblastoma: Insights from advanced imaging for a nuanced understanding of the molecularly defined malignant biology

Quantifying intra-tumoral genetic heterogeneity of glioblastoma toward precision medicine using MRI and a data-inclusive machine learning algorithm

Discrimination Between Glioblastoma and Solitary Brain Metastasis Using Conventional MRI and Diffusion-Weighted Imaging Based on a Deep Learning Algorithm

Radiomics Analysis of Diffusion Kurtosis Imaging: Distinguishing Between Glioblastoma and Single Brain Metastasis

Fusing Multiple Deep Models for in Vivo Human Brain Hyperspectral Image Classification to Identify Glioblastoma Tumor

Machine-learning-based Classification of Glioblastoma Using MRI-based Radiomic Features.

Evaluation of Key Molecular Markers in Adult Diffuse Gliomas Based on a Novel Combination of Diffusion and Perfusion MRI and MR Spectroscopy

Quantitative Evaluation of Diffusion and Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Differentiation Between Primary Central Nervous System Lymphoma and Glioblastoma

Identifying spatial imaging biomarkers of glioblastoma multiforme for survival group prediction.

Machine-learning based classification of glioblastoma using dynamic susceptibility enhanced MR image.